Aggrenox (aspirin/extended release dipyridamole) Capsules

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) November 2015 WARNINGS AND PRECAUTIONS Risk of Bleeding Risk factors for bleeding include the use of other drugs that increase...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts